Articles tagged with “gamp-5”

Explore AI governance frameworks for pharmaceutical companies. Learn to align AI with GxP, FDA regulations, and data integrity standards for safe adoption.

Explore risk-based AI validation strategies using ICH Q9 guidelines. Learn to manage machine learning lifecycle risks in regulated pharma environments.

Learn AI/ML validation in GxP using GAMP 5 2nd Ed. and FDA CSA. Explains risk-based lifecycles, data integrity, and compliance for adaptive models.

Learn to validate AI/ML systems in GxP manufacturing using the GAMP 5 Appendix D11 framework. Explore key considerations for data integrity, risk, and model dri

Learn to apply the GAMP 5 risk-based approach for AI/ML validation in GxP environments. This guide covers data integrity, model drift, and regulatory compliance

Learn how to integrate GAMP 5 (2nd Ed.) and Computer Software Assurance (CSA). This guide details the shift from CSV to a modern, risk-based validation strategy

An in-depth analysis of the 2025 Computer System Validation (CSV) job market. Learn about validation specialist salaries, key skills, and career trends.

Learn the GAMP 5 software categories for computerized system validation. This guide explains each category with examples, risk levels, and how they align with the 2025 ISPE GAMP AI Guide and FDA CSA framework.

Learn the key differences between GAMP 4 and GAMP 5. Updated for 2026 with FDA's finalized CSA guidance, ISPE GAMP AI Guide, and EU GMP Annex 11/22 drafts. Clear migration path for pharma IT.

Updated guide to GAMP 5 guidelines for validating computerized systems, covering the 2025 ISPE GAMP AI Guide, FDA CSA final guidance, EU Annex 11/22 drafts, and risk-based lifecycle approach.

Compare GAMP 4 and GAMP 5. Learn key differences in their approaches to system validation, risk management, system classification, and integration of modern technologies. Updated with 2025 FDA CSA guidance and ISPE GAMP AI Guide.

Learn about 21 CFR Part 11, the FDA regulation for electronic records and signatures. Updated for 2026 with the latest FDA guidance on electronic systems, Computer Software Assurance (CSA), and GAMP 5 Second Edition.

This guide explains GAMP 5, its principles, and lifecycle for computerized system validation in pharma, covering regulatory compliance and real-world applications. Updated for 2025-2026 with FDA CSA guidance, EU Annex 11 revision, and ISPE AI Guide.